419 results
Pharmacology and differences between medications for treating benign prostate hyperplasia (BPH).

#bph #pharmacology #medications #management #prostate
prostate hyperplasia (BPH ... #bph #pharmacology
Therapy for Benign Prostatic Hyperplasia (BPH) 
5 Alpha-Reductase inhibitors
 • Flnasterlde and dutasterlde act by reducing
Prostatic Hyperplasia (BPH ... the symptoms of BPH ... #Hyperplasia #BPH
Benign Prostatic Hyperplasia: Pathogenesis and Medications
Aging
 -> Increased Testosterone -> Testosterone metabolized into DHT by type
inflammation #BPH
Prostate-Specific Antigen (PSA) Test

•	Total PSA (tPSA):
o	Measures overall PSA levels in the blood.
o	Used as the primary screening
differentiate BPH ... prostatecancer #BPH
Benign Prostatic Hyperplasia: Pathogenesis and Clinical Findings

Hormonal alterations (result of aging process)
    ->
bladder stones #BPH
Bladder outlet obstruction (BOO)

Functional obstruction may be caused by detrusor-sphincter dyssynergia (DSD), either at the level
prostatic enlargement (BPH ... prostatic obstruction (BPO ... @DharSaty #BPH
REBEL Review 89: Treatment of Postpartum Hemorrhage #FOAMed #table #obstetrics #hemorrhage #PPH
obstetrics #hemorrhage #PPH
Back to Basics: Postpartum Hemorrhage

#Diagnosis #Management #Postpartum #Hemorrhage #PPH #4Ts #Differential
Postpartum #Hemorrhage #PPH
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
pharmacotherapy trials in BPD ... following outcomes: BPD ... placebo-controlled Managing BPD ... the UK national BPD ... #Pharmacology #BPD
Borderline Personality Disorder: Pathogenesis and Clinical Findings
Behavioral Traits:
 • Unstable Relationships - Alternating extremes of idealization
experienced BPD ... impairment #BPD